| Ansøgningsnr. og dato | 17209680.2 (espacenet) (Federated) (European Patent Register), 20121116 | | Patent/reg.nr. og dato | DK/EP 3366775, 20220427 | | Tilgængelighedsdato | 20180829 | | Prioritetsnr. og dato | US 201161561710 P, 20111118 | | EP publ. nr. og dato |
EP 3366775 20180829 | | Løbedag | | | Ansøger/indehaver | Alnylam Pharmaceuticals, Inc., 300 Third Street
Cambridge, MA 02142, US | | Ansøgers ref. nr. | 2030992 | | Opfinder | Manoharan, Muthiah, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street
Cambridge, MA 02142, US,
Rajeev, Kallanthottathil, G., c/o Alnylam Pharmaceuticals, INC. 300 Third Street
Cambridge, MA 02142, US,
Maier, Martin, c/o Alnylam Pharmaceuticals, INC. 300 Third Street
Cambridge, MA 02142, US,
ZIMMERMANN, Tracy, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street
Cambridge, MA 02142, US,
KUCHIMANCHI, Satyanarayana, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street
Cambridge, MA 02142, US,
CHARISSE, Klaus, c/o Alnylam Pharmaceuticals, Inc.
300 Third Street
Cambridge, MA 02142, US | | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Interessent på tilknyttet sag | | | IPC-Klasse | A61K 31/7125 (2006.01) , C12N 15/113 (2010.01) | | Titel/benævnelse | MODIFICEREDE RNAI-MIDLER | | Internationalt ansøgningsnr. | | | Internationalt publ. nr. | | | Relateret sag (certifikat) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
